Feasibility of sputum induction in lung transplant recipients

Clinical Transplantation

Volumn 18, Issue 5, 2004, Pages 605-612

  van den Berg, Jan W K ^a   Slebos, Dirk Jan ^a   Postma, Dirkje S ^a   Dijkhuizen, Brigitte ^a   Koëter, Gerard H ^a   Timens, Wim ^a   der van Bij, Wim ^a   Kauffman, Henk F ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Bronchiolitis obliterans; Lung transplantation; Sputum induction

Indexed keywords

ACICLOVIR; AZATHIOPRINE; COTRIMOXAZOLE; CYCLOSPORIN; INTERLEUKIN 8; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; SODIUM CHLORIDE; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; BRONCHIOLITIS; CLINICAL ARTICLE; CONTAMINATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; FEASIBILITY STUDY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; LEUKOCYTE COUNT; LUNG DISEASE; LUNG LAVAGE; LUNG TRANSPLANTATION; MALE; NEUTROPHIL; PATHOGENESIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION; SPUTUM ANALYSIS; SPUTUM LEVEL; SQUAMOUS CELL;

ADULT; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOSCOPY; CELL COUNT; EPITHELIAL CELLS; FEASIBILITY STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; INTERLEUKIN-8; LEUKOCYTE COUNT; LUNG; LUNG TRANSPLANTATION; MACROPHAGES; MALE; MIDDLE AGED; NEBULIZERS AND VAPORIZERS; NEUTROPHILS; SALINE SOLUTION, HYPERTONIC; SPUTUM;

EID: 4644277723     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2004.00237.x     Document Type: Article

References (41)

1. Hosenpud JD, Bennett LE, Keck BM, Boucek MM, Novick RJ. The registry of the international society for heart and lung transplantation: seventeenth official report. J Heart Lung Transplant 19: 909.
2. vd Berg JW, Geertsma A, vd Bij W et al. Bronchiolitis obliterans syndrome after lung transplantation and health-related quality of life. Am J Respir Crit Care Med 2000: 161: 1937.
3. Revell MP, Lewis ME, Llewellyn-Jones CG, Wilson IC, Bonser RS. Conservation of small-airway function by tacrolimus/cyclosporine conversion in the management of bronchiolitis obliterans following lung transplantation. J Heart Lung Transplant 2000: 19: 1219.
4. Kelly K, Hertz MI. Obliterative bronchiolitis. Clin Chest Med 1997: 18: 319.
5. Scholma J, Slebos DJ, Boezen HM et al. Eosinophilic granulocytes and interleukin-6 level in bronchoalveolar lavage fluid are associated with the development of obliterative bronchiolitis after lung transplantation. Am J Respir Crit Care Med 2000: 162: 2221.
6. Cooper JD, Billingham M, Egan T et al. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation. J Heart Lung Transplant 1993: 12: 713.
7. Yousem SA, Paradis I, Griffith BP. Can transbronchial biopsy aid in the diagnosis of bronchiolitis obliterans in lung transplant recipients? Transplantation 1994: 57: 151.
8. Kramer MR, Stoehr C, Whang JL et al. The diagnosis of obliterative bronchiolitis after heart-lung and lung transplantation: low yield of transbronchial lung biopsy. J Heart Lung Transplant 1993: 12: 675.
9. Chaparro C, Maurer JR, Chamberlain DW, Todd TR. Role of open lung biopsy for diagnosis in lung transplant recipients: ten-year experience. Ann Thorac Surg 1995: 59: 928.
10. Chan CC, Abi ST, Arroliga AC et al. Diagnostic yield and therapeutic impact of flexible bronchoscopy in lung transplant recipients. J Heart Lung Transplant 1996: 15: 196.
11. Tiroke AH, Bewig B, Haverich A. Bronchoalveolar lavage in lung transplantation. State of the art. Clin Transplant 1999: 13: 131.
12. Ward C, Whitford H, Snell G et al. Bronchoalveolar lavage macrophage and lymphocyte phenotypes in lung transplant recipients. J Heart Lung Transplant 2001: 20: 1064.
13. Zheng L, Walters EH, Ward C et al. Airway neutrophilia in stable and bronchiolitis obliterans syndrome patients following lung transplantation. Thorax 2000: 55: 53.
14. Slebos DJ, Scholma J, Boezen HM et al. Longitudinal profile of bronchoalveolar lavage cell characteristics in patients with a good outcome after lung transplantation. Am J Respir Crit Care Med 2002: 165: 501.
15. Henke JA, Golden JA, Yelin EH, Keith FA, Blanc PD. Persistent increases of BAL neutrophils as a predictor of mortality following lung transplant. Chest 1999: 115: 403.
16. Keatings VM, Collins PD, Scott DM, Barnes PJ. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 1996: 153: 530.
17. Pizzichini E, Pizzichini MM, Kidney JC et al. Induced sputum, bronchoalveolar lavage and blood from mild asthmatics: inflammatory cells, lymphocyte subsets and soluble markers compared. Eur Respir J 1998: 11: 828.
18. Alexis NE, Hu SC, Zeman K, Alter T, Bennett WD. Induced sputum derives from the central airways: confirmation using a radiolabeled aerosol bolus delivery technique. Am J Respir Crit Care Med 2001: 164: 1964.
19. Yousem SA, Paradis IL, Dauber JA et al. Large airway inflammation in heart-lung transplant recipients - its significance and prognostic implications. Transplantation 1990: 49: 654.
20. Yousem SA, Duncan SR, Ohori NP, Sonmez-Alpan E. Architectural remodeling of lung allografts in acute and chronic rejection. Arch Pathol Lab Med 1992: 116: 1175.
21. Ward C, Snell GI, Orsida B, Zheng L, Williams TJ, Walters EH. Airway versus transbronchial biopsy and BAL in lung transplant recipients: different but complementary. Eur Respir J 1997: 10: 2876.
22. Zheng L, Ward C, Snell GI et al. Scar collagen deposition in the airways of allografts of lung transplant recipients. Am J Respir Crit Care Med 1997: 155: 2072.
23. Rutgers SR, Timens W, Kaufman HF, van der Mark ThW, Koëter GH, Postma DS. Comparison of induced sputum with bronchial wash, bronchoalveolar lavage and bronchial biopsies in COPD. Eur Respir J 2000: 15: 109.
24. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986: 1: 307.
25. Trulock EP. Lung transplantation. Am J Respir Crit Care Med 1997: 155: 789.
26. Nightingale JA, Rogers DF, Barnes PJ. Effect of repeated sputum induction on cell counts in normal volunteers. Thorax 1998: 53: 87.
27. Holz O, Richter K, Jörres RA, Speckin P, Mucke M, Magnussen H., Changes in sputum composition between two inductions performed on consecutive days. Thorax 1998: 53: 83.
28. Beeh KM, Kornmann O, Lill J, Buhl R. Induced sputum cell profiles in lung transplant recipients with or without chronic rejection: correlation with lung function. Thorax 2001: 56: 557.
29. Hunter CJ, Ward R, Woltmann G, Wardlaw AJ, Pavord ID. The safety and success rate of sputum induction using a low output ultrasonic nebuliser. Respir Med 1999: 93: 345.
30. Maestrelli P, Saetta M, Di Stefano A et al. Comparison of leukocyte counts in sputum, bronchial biopsies, and bronchoalveolar lavage. Am J Respir Crit Care Med 1995: 152: 1926.
31. Keatings VM, Evans DJ, O'Connor BJ, Barnes PJ. Cellular profiles in asthmatic airways: a comparison of induced sputum, bronchial washings, and bronchoalveolar lavage fluid. Thorax 1997: 52: 372.
32. Bustamante EA, Levy H. Sputum induction compared with bronchoalveolar lavage by Ballard catheter to diagnose Pneumocystis carinii pneumonia. Chest 1994: 105: 816.
33. Van Muylem A, Paiva M, Estenne M. Involvement of peripheral airways during methacholine-induced bronchoconstriction after lung transplantation. Am J Respir Crit Care Med 2001: 164: 1200.
34. Fahy JV, Wong H, Liu J, Boushey HA. Comparison of samples collected by sputum induction and bronchoscopy from asthmatic and healthy subjects. Am J Respir Crit Care Med 1995: 152: 53.
35. Dippolito R, Foresi A, Chetta A et al. Eosinophils in induced sputum from asymptomatic smokers with normal lung function. Respir Med 2001: 95: 969.
36. Leigh TR, Jones BE, Ryan P, Collins JV. The use of inhaled radioisotopes for measuring the effect of sputum induction on tracheobronchial clearance rates. Nucl Med Commun 1994: 15: 156.
37. Moodley YP, Krishnan V, Lalloo UG. Neutrophils in induced sputum arise from central airways. Eur Respir J 2000: 15: 36.
38. Sibille Y, Marchandise FX. Pulmonary immune cells in health and disease: polymorphonuclear neutrophils. Eur Respir J 1993: 6: 1529.
39. DiGiovine B, Lynch JP, Martinez FJ et al. Bronchoalveolar lavage neutrophilia is associated with obliterative bronchiolitis after lung transplantation: role of IL-8. J Immunol 1996: 157: 4194.
40. Riise GC, Williams A, Kjellstrom C, Schersten H, Andersson BA, Kelly FJ. Bronchiolitis obliterans syndrome in lung transplant recipients is associated with increased neutrophil activity and decreased antioxidant status in the lung. Eur Respir J 1998: 12: 82.
41. Beeh KM, Beier J, Kornmann O, Micke P, Buhl R. Sputum levels of metalloproteinase-9 and tissue inhibitor of metalloproteinase-1, and their ratio correlate with airway obstruction in lung transplant recipients: relation to tumor necrosis factor-α and interleukin-10. J Heart Lung Transplant 2001: 20: 1144.